Viewing StudyNCT02474290



Ignite Creation Date: 2024-05-06 @ 7:09 AM
Last Modification Date: 2024-10-26 @ 11:45 AM
Study NCT ID: NCT02474290
Status: COMPLETED
Last Update Posted: 2019-08-26
First Post: 2015-06-14

Brief Title: Sorafenib for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3-ITD Positive AML
Sponsor: Nanfang Hospital Southern Medical University
Organization: Nanfang Hospital Southern Medical University

Conditions & Keywords Data

Conditions:
Name
Hematopoietic Stem Cell Transplantation
Acute Myeloid Leukemia
Keywords:
Name View
Hematopoietic Stem Cell Transplantation View
Acute Myeloid Leukemia View
FLT3-ITD View